Cerebrospinal fluid studies in the Rett syndrome: biogenic amines and beta-endorphins.
The etiology of the Rett syndrome (RS) is unknown. Reduced function of biogenic amines has been described. Symptoms of central apnea, hyperventilation, hypothermia, peripheral analgesia, muscle rigidity, myoclonic jerks, hand stereotypy and seizures occur in RS and have been suggested as a result of elevated central beta-endorphins. It was hypothesized that a dysfunctional modulation of endogenous opiate systems and biogenic amines may be present. Cerebrospinal fluid (CSF) from 12 girls with RS was studied for beta-endorphin immunoreactivity, and biogenic amines. Lactates and pyruvate levels were measured. Eleven of the 12 girls had elevated beta-endorphin immunoreactivity in CSF, 4 girls had reduced biogenic amines and 6 girls had elevated pyruvate and lactate levels. Whether the elevated beta-endorphin immunoreactivity is a primary disorder or is a result of secondary feedback mechanisms is unknown. Naltrexone, an antiopioid drug, may reduce symptoms.
Budden
S S
SS
Department of Pediatrics, Oregon Health Sciences University, Portland 97207.
Myer
E C
EC
Butler
I J
IJ
D000293:Adolescent; D001679:Biogenic Amines / Q000134:cerebrospinal fluid*; D002648:Child; D002675:Child, Preschool; D004723:Endorphins / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D015518:Rett Syndrome / Q000134:cerebrospinal fluid*
D001679:Biogenic Amines; D004723:Endorphins; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid